Clinical trial
Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis (SUPERB-CF)
NCT04297709 is registered in ClinicalTrials.gov with Mologic Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis (SUPERB-CF)
- Lead sponsor
- Mologic Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2018
- Completion date
- July 31, 2019
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.